Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04423055 · ClinicalTrials.gov registry record · Phase 4
Nexplanon Use in Women Primarily Choosing a Combined Oral Contraceptive
A Phase 4 study, sponsored by University of California, Davis.
- Completed
- Registry status
- Phase 4
- Development phase
- 120
- Enrollment target
NCT04423055 is a Phase 4 study that has completed, run by University of California, Davis. The registered enrollment target is 120 participants.
The verdict
NCT04423055, a Phase 4 study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 120 participants
- Enrollment target
Study Summary
Women currently using or starting a combined oral contraceptive (COC) will be offered study enrollment. Study subjects will have a Nexplanon placed and followed for approximately 12 months to evaluate if they continue the implant, the COC, or both, and to assess bleeding patterns and adverse events.
Interventions
- DRUG Etonogestrel contraceptive implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2020-08-13 |
| Est. Completion | 2024-04-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04423055
The ClinicalTrials.gov registry entry for NCT04423055 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Etonogestrel contraceptive implant is the first listed.
NCT04423055 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04423055 about?
NCT04423055 is a clinical study titled "Nexplanon Use in Women Primarily Choosing a Combined Oral Contraceptive". Women currently using or starting a combined oral contraceptive (COC) will be offered study enrollment. Study subjects will have a Nexplanon placed and followed for approximately 12 months to evaluate if they continue the implant, the COC, or both, and to assess bleeding patterns and adverse events.
What is the current status of trial NCT04423055?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 120 participants. The study started on 2020-08-13. Estimated completion is 2024-04-09.
What interventions are being tested in trial NCT04423055?
The interventions under investigation include: Etonogestrel contraceptive implant (DRUG).
Who is sponsoring clinical trial NCT04423055?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.